You cannot edit this Postr after publishing. Are you sure you want to Publish?
Experience reading like never before
Sign in to continue reading.
"It was a wonderful experience interacting with you and appreciate the way you have planned and executed the whole publication process within the agreed timelines.”
Subrat SaurabhAuthor of Kuch Woh PalThis Book Introduction to Small and Non- Small Lung Cancer Patients Worldwide, the annual number of new cases of lung cancer is estimated at more than one million and is expected to increase to ten million in 2025. Fortunately, the political efforts to reduce the use of tobacco are getting increasing attention in many countries and the Statistics are now showing the first positive results. Among the epidemiologic changes we also see a change in the histopathologic pattern, with a relative decrease in squamous cell carcinoma and a rise in adenocarcinoma. Lately, important new information as regards the biology of lung cancer is emerging, including new treatment approaches. The result is a slow, but steady improvement of the overall management of lung cancer based on an increasing use of combined modality therapy, consisting of surgery, chemotherapy, and radiotherapy applied concurrently or sequentially in early stage disease. Furthermore, new techniques are gaining ground, both within surgery and radiotherapy and targeted medical therapy is being offered to more and more patients. Delivery of National Health Service cancer care has improved. Despite these improvements, lung cancer remains a scourge worldwide, with a poor outlook that is clearly related to smoking habits. Improving treatments and care will not replace, but reinforce the need for concerted worldwide tobacco control.
Mr. S. Azhagu Madhavan, Dr. S. Ganesan, Dr. M. Mahadevi
Mr. S. Azhagu Madhavan, M.Sc., PGDCA., PGDBI., Ph.D., Research scholar, He has completed M.Sc., and Ph.D., Zoology from PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi Thanjavur Dt., Tamilnadu, India. Mr. S. Azhagu Madhavan, Research group is involved in studying Cell and molecular signatures with special reference to Bioinformatics & Statistical tools Software knowledge, Mendeley, SPSS, NCBI, Origin pro-8 & Gene & Protein Sequence, Multiple Sequence Analysis, Pathway Analysis, DAVID -Bioinformatics resources & Tools. Molecular Docking Diabetes Mellitus. Our research integrates physiological and pharmacological techniques to study mechanisms underlying development and progressions of Cancer. He has presented 43 papers in National and International conference, lecture workshop and National seminar published 17 Research paper in well-reputed journals.
The items in your Cart will be deleted, click ok to proceed.